These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 3598982)
41. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients. Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157 [TBL] [Abstract][Full Text] [Related]
42. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development? Burkhardt O; Lehmann C; Madabushi R; Kumar V; Derendorf H; Welte T J Antimicrob Chemother; 2006 Oct; 58(4):822-9. PubMed ID: 16885180 [TBL] [Abstract][Full Text] [Related]
43. Gentamicin and tobramycin in neonates: comparison of a new extended dosing interval regimen with a traditional multiple daily dosing regimen. Avent ML; Kinney JS; Istre GR; Whitfield JM Am J Perinatol; 2002 Nov; 19(8):413-20. PubMed ID: 12541213 [TBL] [Abstract][Full Text] [Related]
44. [Pharmacokinetics of metronidazole during perioperative short-term prophylaxis in cesarean section]. Amon I; Amon K; Zschiesche M Wien Klin Wochenschr; 1983 Aug; 95(16):562-5. PubMed ID: 6649641 [TBL] [Abstract][Full Text] [Related]
45. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [TBL] [Abstract][Full Text] [Related]
46. Risk factors for febrile morbidity associated with cesarean section. Rehu M; Nilsson CG Obstet Gynecol; 1980 Sep; 56(3):269-73. PubMed ID: 7422164 [TBL] [Abstract][Full Text] [Related]
47. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis]. Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880 [TBL] [Abstract][Full Text] [Related]
48. [Puerperal endometritis: study of 52 clinically and microbiologically diagnosed cases]. Bosch J; Pericot A; Amorós M; Ros R Enferm Infecc Microbiol Clin; 1995 Apr; 13(4):203-8. PubMed ID: 7779871 [TBL] [Abstract][Full Text] [Related]
49. [Use of desamino-oxytocin in postpartum endometritis]. Gurtovoĭ BL; Gromova AM Vopr Okhr Materin Det; 1977 May; 22(5):62-6. PubMed ID: 560755 [No Abstract] [Full Text] [Related]
54. Efficacy of different dosing schedules of tobramycin for treating a murine Klebsiella pneumoniae bronchopneumonia. Pechère M; Letarte R; Pechère JC J Antimicrob Chemother; 1987 Apr; 19(4):487-91. PubMed ID: 3294779 [TBL] [Abstract][Full Text] [Related]
55. Intramuscular tobramycin pharmacokinetics in geriatric patients. Mayer PR; Brown CH; Carter RA; Welty TE; Millikan MD; Eberhard NK Drug Intell Clin Pharm; 1986; 20(7-8):611-5. PubMed ID: 3743420 [TBL] [Abstract][Full Text] [Related]
56. [Clinical aspects and therapy of puerperal endometritis]. Akkerman LI Akush Ginekol (Mosk); 1970 Oct; 46(10):38-40. PubMed ID: 5519735 [No Abstract] [Full Text] [Related]
57. [Therapeutic use of vibramycin in obstetrics]. Bertić BM Med Pregl; 1976; 29(1-2):73-6. PubMed ID: 1256373 [No Abstract] [Full Text] [Related]
58. A pharmacokinetic evaluation of the effect of plasma exchange on tobramycin disposition. Ouellette SM; Visconti JA; Kennedy MS Clin Exp Dial Apheresis; 1983; 7(3):225-33. PubMed ID: 6671353 [TBL] [Abstract][Full Text] [Related]
59. [Adjustment of tobramycin doses. Lack of reliability of a simple nomogram]. Martin C; Saux P; Bruguerolle B; Mallet MN; Haddad C; Gouin F Presse Med; 1988 Feb; 17(5):209. PubMed ID: 2965378 [No Abstract] [Full Text] [Related]
60. [The problem in the incubation of injective solutions. The difference between ampule and vial]. Okada K; Kawamura N; Ohkoshi M Jpn J Antibiot; 1985 Oct; 38(10):2815-20. PubMed ID: 4078994 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]